Velocity and density gradient analysis of Sec2p-exocyst binding. (A) NY2546 (Sec2p, Sec15-13xmycp), NY2547 (Sec2-GFPp, Sec15-13xmycp), and NY2549 (Sec2-78-GFPp, Sec15-13xmycp) lysates were subjected to velocity gradient centrifugation following detergent solubilization as described in Materials and Methods. Fifteen fractions were collected from the top and analyzed for the presence of Sec2p and Sec15p by Western blotting. From fractions 4 to 9, Sec2-GFPp was immunoprecipitated with anti-GFP, and Sec15-13xmycp present in the immunoprecipitations (IPs) was detected by anti-myc. One percent of Sec15p present in fractions 7, 8, and 9 can be coprecipitated with Sec2-GFPp; 5% of Sec15p present in fractions 7, 8, and 9 can be coprecipitated with Sec2-78-GFPp. No Sec15p was detected in the immunoprecipitates from the control strain containing untagged Sec2p. The efficiency of αGFP precipitation was typically 80%. (B) The sedimentation profiles of Sec2p and Sec15-13xmycp in wild-type (closed symbols) and sec2-78 cells (open symbols) in 10–35% glycerol velocity gradients. (C) Precleared lysates of NY2547 (Sec2-GFPp, Sec15-13xmycp) and NY2549 (Sec2-78-GFPp, Sec15–13xmycp), and NY2546 (Sec2p, Sec15-13xmycp) were loaded at the bottom of a tube containing 35% iodixanol and centrifuged as described in Materials and Methods. Seven fractions were collected from the top. The amount of Sec2p, Sec15p, Ssop, and Adhp in each fraction was determined by Western blotting. The left panels show data for a strain expressing Sec2-GFPp (NY2547); the middle panels show data for a strain expressing Sec2-78-GFPp (NY2549). As a negative control, the identical experiment was also performed with a strain expressing untagged Sec2p (NY2546, right). For each fractionation experiment, a portion of each of the seven fractions was subjected to immunoprecipitation with anti-GFP and Sec15p was detected with anti-myc (bottom). The efficiency of αGFP precipitation was typically 70–80%. The input lane in all IP blots (bottom) represents 2.5% of Sec15-13xmycp present in fraction 1 (lane 8) and 2.5% of total Sec15-13xmycp in each lysate before the fractionation (lane 9). No Sec15-13xmycp was detected in a control αGFP precipitation from a strain expressing untagged Sec2p (NY2546). (D) Precleared lysates of NY2547(Sec2-GFPp, Sec15-13xmycp) and NY2546 (Sec2p, Sec15-13xmycp) were loaded on top of 20–40% sorbitol gradient and centrifuged as described in Materials and Methods. Fourteen fractions were collected from the top, and 2% of each fraction was analyzed for the amount of Sec22p, Sncp, Sec2p, Sec15p, Sec4p, Ssop, and Adh1p by Western blotting with an antibody raised against each protein except Sec15p, which was detected with αmyc. Input represents 0.14% of total protein loaded on top of the gradient. The distribution of markers upon fractionation of lysates prepared from strain NY2547 and a control strain NY2546 looked identical; therefore, only data for NY2547 are shown. A portion of each fraction was immunoprecipitated with αGFP, and the amount of Sec15-13mycp in the immunoprecipitates was determined with αmyc. Sec2-GFPp in the immunoprecipitates was detected with αSec2p. The input lane represents 0.05% of total protein loaded on top of the gradient. Control IPs represent identical immunoprecipitation experiments with the control strain NY2546 expressing untagged Sec2p.